Canada’s Jamp Creates Dedicated Biosimilars Division
As It Prepares To Launch Alvotech’s Higher-Strength Adalimumab Humira Rival
• By David Wallace
Montreal-based Jamp welcomes a new dawn for its biosimilars business • Source: James Byrne / Alamy Stock Photo 
